Building Your Care Team and Long-Term Monitoring
At a Glance
FLNA-related periventricular nodular heterotopia requires coordinated long-term care: neurology, genetics, cardiology, and pulmonology teams may monitor seizures, the aorta, blood pressure, lung function, and family genetic risk.
Managing Periventricular Nodular Heterotopia (PVNH)—especially the FLNA-related type—requires a team that looks beyond the brain. Because this genetic change affects the framework of cells throughout the body, you need a group of specialists who communicate with each other to monitor your heart, lungs, and neurological health [1][2].
Your Multidisciplinary Care Team
A “multidisciplinary” team means several specialists working together. For FLNA-related PVNH, this typically includes:
- Epileptologist/Neurologist: This is a neurologist who specializes in epilepsy. They manage seizure medications and, if needed, evaluate whether advanced procedures like LITT or RNS are appropriate [3][4].
- Medical Geneticist & Genetic Counselor: They confirm the specific gene involved (like FLNA, ARFGEF2, or MAP1B) and help you understand what that means for your health and your family members [5][6].
- Cardiologist (Aortopathy Specialist): This is perhaps the most critical addition for FLNA patients. You should ideally see a cardiologist familiar with aortopathies (diseases of the aorta), as they understand that surgical thresholds may be different for FLNA than for conditions like Marfan syndrome [7][8].
- Pulmonologist: They monitor for lung issues like emphysema or pulmonary hypertension (high blood pressure in the lung arteries), which can occur in some genetic subtypes [9][10].
Long-Term Monitoring Schedule
While your team will create a plan unique to you, specialist-directed monitoring for FLNA-related PVNH often includes the following:
Cardiovascular (Heart & Vessels)
- Baseline: At the time of diagnosis, you should have an echocardiogram to look at the heart valves and a vascular MRI (or CT) to see the entire length of the aorta [11][7].
- Ongoing Surveillance: Because the risk of aortic enlargement or tearing (dissection) is lifelong, you will need “serial” imaging. The interval and modality depend entirely on the initial aortic measurements, growth rate, age, variant, family history, and cardiology advice [7][12].
- Blood Pressure: Regular, accurate blood pressure checks are essential [7].
Pulmonary (Lungs)
The Importance of Family Evaluation
PVNH is often a “silent” condition. In many families, a child is the first person diagnosed, but further testing reveals that a parent or grandparent also has the condition without ever knowing it [14].
- Inheritance: The FLNA gene follows an X-linked dominant inheritance pattern. This means a heterozygous female generally has a 50% chance in each pregnancy of passing on the variant, whereas an affected male transmits an FLNA variant to all daughters and no sons [6].
- Targeted Screening: A known familial pathogenic variant should generally lead to targeted genetic testing through genetics for first-degree relatives (parents, siblings, children). This is followed by organ-specific evaluation for confirmed carriers. A blanket brain MRI for asymptomatic relatives is not automatically indicated [6][7].
- Genetic Counseling: Professional genetic counseling is strongly recommended for reproductive decision-making and assessing which relatives should be offered testing.
When meeting a new doctor, it is okay to “interview” them to ensure they have the right expertise. Consider asking if they have experience with FLNA mutations or PVNH, and if they have a protocol for screening asymptomatic family members based on genetic results.
Common questions in this guide
Which specialists should care for someone with FLNA-related PVNH?
What heart tests are needed when FLNA-related PVNH is diagnosed?
How is lung health monitored in FLNA-related PVNH?
Should family members have genetic testing for FLNA-related PVNH?
How is FLNA-related PVNH inherited?
When might monitoring change to aortic surgery?
Get notified when new evidence is published on Periventricular nodular heterotopia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
"Phenotypic and genotypic insights, counseling strategies, and follow-up in 24 individuals with filamin a deficiency: findings from a retrospective cohort study".
Rijckmans E, De Strooper L, Keymolen K, et al.
Acta neurologica Belgica 2025; (125(5)):1347-1356 doi:10.1007/s13760-025-02858-0.
PMID: 40758172 - 2
Phenotypic manifestations in FLNA-related periventricular nodular heterotopia: a case report and review of the literature.
Loft Nagel J, Jønch AE, Nguyen NTTN, Bygum A
BMJ case reports 2022; (15(4)) doi:10.1136/bcr-2021-247268.
PMID: 35414575 - 3
The phenotypic spectrum of epilepsy associated with periventricular nodular heterotopia.
Paliotti K, Dassi C, Berrahmoune S, et al.
Journal of neurology 2023; (270(8)):3934-3945 doi:10.1007/s00415-023-11724-z.
PMID: 37119372 - 4
Laser Ablation of Periventricular Nodular Heterotopia for Medically Refractory Epilepsy.
McCormack RM, Chandran AS, Lhatoo SD, et al.
Annals of neurology 2024; (96(6)):1174-1184 doi:10.1002/ana.27059.
PMID: 39297387 - 5
FLNA genomic rearrangements in a 391 French bilateral periventricular nodular heterotopia cohort: prevalence and phenotypic correlations.
Margot H, Hernandez Poblete N, Angelini C, et al.
Journal of medical genetics 2025; (62(4)):227-230 doi:10.1136/jmg-2024-110336.
PMID: 39779312 - 6
47 patients with FLNA associated periventricular nodular heterotopia.
Lange M, Kasper B, Bohring A, et al.
Orphanet journal of rare diseases 2015; (10()):134 doi:10.1186/s13023-015-0331-9.
PMID: 26471271 - 7
Thoracic aortic aneurysm in patients with loss of function Filamin A mutations: Clinical characterization, genetics, and recommendations.
Chen MH, Choudhury S, Hirata M, et al.
American journal of medical genetics. Part A 2018; (176(2)):337-350 doi:10.1002/ajmg.a.38580.
PMID: 29334594 - 8
Extended Root and Arch Replacement for Filamin A-Related Aortopathy With Severe Aortic Regurgitation.
Oda R, Goto K, Arakawa A, et al.
JACC. Case reports 2026; (31(17)):107533 doi:10.1016/j.jaccas.2026.107533.
PMID: 41860486 - 9
Pulmonary hypertension in patients carrying FLNA loss-of-function variants.
Stourm L, Grynblat J, Savale L, et al.
The European respiratory journal 2025; (65(3)) doi:10.1183/13993003.01132-2024.
PMID: 39510553 - 10
Heterogeneous Pulmonary Phenotypes in Filamin A Mutation-Related Lung Disease.
Shah AS, Black ED, Simon DM, et al.
Pediatric allergy, immunology, and pulmonology 2021; (34(1)):7-14 doi:10.1089/ped.2020.1280.
PMID: 33734874 - 11
Asymmetrical aortic root aneurism in patient with Filamin A mutation.
Martin-Suarez S, Gliozzi G, Pagano V, et al.
Journal of cardiac surgery 2022; (37(10)):3408-3412 doi:10.1111/jocs.16765.
PMID: 35819109 - 12
Linear growth pattern can be used to predict ascending aortic aneurysm growth.
Viitala IM, Selander T, Hedman M, Turtiainen J
Scandinavian cardiovascular journal : SCJ 2024; (58(1)):2430001 doi:10.1080/14017431.2024.2430001.
PMID: 39560133 - 13
Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know - but is afraid to ask!
Sanges S, Sobanski V, Lamblin N, et al.
La Revue de medecine interne 2024; (45(1)):26-40 doi:10.1016/j.revmed.2023.10.450.
PMID: 37925256 - 14
Three Generations of FLNA-Associated Periventricular Nodular Heterotopia.
Eisenbiegler GE, Brown SA
Case reports in neurology 2021; (13(3)):777-781 doi:10.1159/000519507.
PMID: 35082648
This page explains care coordination and monitoring for FLNA-related PVNH for educational purposes and does not replace medical advice. Your neurologist, geneticist, cardiologist, and pulmonologist should tailor testing and follow-up to you or your child.